18-23541422-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The NM_000271.5(NPC1):c.2257G>A(p.Val753Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00021 in 1,614,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000271.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPC1 | NM_000271.5 | c.2257G>A | p.Val753Met | missense_variant | 15/25 | ENST00000269228.10 | NP_000262.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPC1 | ENST00000269228.10 | c.2257G>A | p.Val753Met | missense_variant | 15/25 | 1 | NM_000271.5 | ENSP00000269228.4 | ||
NPC1 | ENST00000591051.1 | c.1333G>A | p.Val445Met | missense_variant | 8/18 | 2 | ENSP00000467636.1 | |||
NPC1 | ENST00000540608.5 | n.2171G>A | non_coding_transcript_exon_variant | 13/16 | 2 | |||||
NPC1 | ENST00000586718.1 | n.-50G>A | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251422Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135888
GnomAD4 exome AF: 0.000215 AC: 314AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.000227 AC XY: 165AN XY: 727246
GnomAD4 genome AF: 0.000164 AC: 25AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74358
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 29, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 19, 2024 | - - |
Niemann-Pick disease, type C1 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
NPC1-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 20, 2024 | The NPC1 c.2257G>A variant is predicted to result in the amino acid substitution p.Val753Met. This variant has not been reported in an individual with ataxia and assessed as a variant of unknown significance (Vural et al. 2021. PubMed ID: 33624863). This variant is reported in 0.039% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at